World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
33103
World Ranking
10475
National Ranking
5389

Overview

Brian M. Wolpin is affiliated with Harvard University in the United States. Their research spans multiple fields, primarily focusing on medicine and biochemistry, genetics, and molecular biology. Within these broad areas, their work concentrates on several subfields including oncology, molecular biology, cancer research, pulmonary and respiratory medicine, and surgery.

The scientist's research topics display a strong emphasis on oncology-related studies, particularly pancreatic and hepatic oncology research. Other main areas of interest include cancer genomics and diagnostics, cancer immunotherapy and biomarkers, cancer cells and metastasis, epigenetics and DNA methylation, renal cell carcinoma treatment, and colorectal cancer treatments and studies.

Brian M. Wolpin has authored numerous papers published in various respected scientific journals. Notable recent publications include:

  • Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology (2021) in the Journal of the National Comprehensive Cancer Network
  • Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer (2021) in Cell
  • BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial (2020) in Nature Medicine
  • The Mediterranean diet, plasma metabolome, and cardiovascular disease risk (2020) in European Heart Journal
  • Low glycaemic diets alter lipid metabolism to influence tumour growth (2021) in Nature

The scientist frequently collaborates with fellow researchers with whom they have multiple joint publications. Prominent co-authors include Andrew J. Aguirre, James M. Cleary, Lauren K. Brais, Kimmie Ng, and Jonathan A. Nowak.

Brian M. Wolpin's work has been distributed widely across several notable publication venues, reflecting the scope of their research output. These journals are:

  • Cancer Research
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Cancer Epidemiology Biomarkers & Prevention
  • Nature Communications

Best Publications

  • Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

    Vasanthi S. Viswanathan;Matthew J. Ryan;Harshil D. Dhruv;Shubhroz Gill

  • Pancreatic adenocarcinoma, version 2.2017: Clinical practice guidelines in Oncology

    Margaret A. Tempero;Mokenge P. Malafa;Mahmoud Al-Hawary;Horacio Asbun

  • Pancreatic adenocarcinoma, Version 2.2021

    Margaret A. Tempero;Mokenge P. Malafa;Mahmoud Al-Hawary;Stephen W. Behrman

  • Organoid profiling identifies common responders to chemotherapy in pancreatic cancer

    Hervé Tiriac;Pascal Belleau;Dannielle D Engle;Dennis Plenker

  • Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer

    Laufey Amundadottir;Peter Kraft;Rachael Z. Stolzenberg-Solomon;Charles S. Fuchs

  • A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33

    Gloria M. Petersen;Laufey Amundadottir;Charles S. Fuchs;Peter Kraft

  • Systemic Treatment of Colorectal Cancer

    Brian M. Wolpin;Robert J. Mayer

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Kevin B. Jacobs;Meredith Yeager;Meredith Yeager;Weiyin Zhou;Weiyin Zhou;Sholom Wacholder

  • Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development

    Jared R Mayers;Chen Wu;Chen Wu;Clary B Clish;Peter Kraft

  • Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases A Mendelian Randomization Study

    Philip C Haycock;Stephen Burgess;Aayah Nounu

  • Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers

    Jared R. Mayers;Margaret E. Torrence;Laura V. Danai;Thales Papagiannakopoulos

  • ABO Blood Group and the Risk of Pancreatic Cancer

    Brian M. Wolpin;Andrew T. Chan;Patricia Hartge;Stephen J. Chanock

  • Pancreatic Adenocarcinoma, Version 2.2014

    Margaret A. Tempero;Mokenge P. Malafa;Stephen W. Behrman;Al B. Benson

  • Acquired Resistance to KRASG12C Inhibition in Cancer

    Mark M Awad;Shengwu Liu;Igor I Rybkin;Kathryn C Arbour

  • Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).

    Alan A. Arslan;Kathy J. Helzlsouer;Charles Kooperberg;Xiao Ou Shu

  • Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma

    Brian M. Wolpin;Douglas A. Rubinson;Xiaoxu Wang;Jennifer A. Chan

  • BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    Bruno Bockorny;Bruno Bockorny;Valerya Semenisty;Teresa Macarulla;Erkut Borazanci

  • Adjuvant treatment of colorectal cancer.

    Brian M. Wolpin;Jeffrey A. Meyerhardt;Harvey J. Mamon;Robert J. Mayer

  • Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers

    J. R. Mayers;M. E. Torrence;L. V. Danai;T. Papagiannakopoulos

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Meredith Yeager;Weiyin Zhou;Sholom Wacholder

Frequent Co-Authors

Peter Kraft
Peter Kraft Harvard University
Laufey T. Amundadottir
Laufey T. Amundadottir National Institutes of Health
J. Michael Gaziano
J. Michael Gaziano Brigham and Women's Hospital
Julie E. Buring
Julie E. Buring Brigham and Women's Hospital
Alison P. Klein
Alison P. Klein Johns Hopkins University
Howard D. Sesso
Howard D. Sesso Harvard Medical School
Harvey A. Risch
Harvey A. Risch Yale University
Dimitrios Trichopoulos
Dimitrios Trichopoulos Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career isn’t limited to traditional MD routes. Today, a variety of online direct entry msn programs for non-nursing majors offer a fast-track into advanced nursing for students with a bachelor’s degree in another field. These accelerated options provide a flexible path to entering healthcare without starting from scratch.

For those interested in patient care but not ready for a master’s, online bsn programs for non nurses open doors to becoming a Registered Nurse. These programs are designed for career changers and often feature streamlined admission requirements.

The medical field also needs skilled professionals behind the scenes. online medical billing and coding with financial aid programs train students for vital administrative roles, often in under two years, and can be completed entirely online.

If you’re looking for quicker entry into healthcare, lpn school without teas test options allow you to skip lengthy entrance exams and start your training sooner.

These alternative pathways make it easier than ever to launch a rewarding healthcare career without a traditional medical degree.

Best Scientists Citing Brian M. Wolpin

Trending Scientists